Cullinan Therapeutics Inc (CGEM) — institutional ownership

193 funds reported holding Cullinan Therapeutics Inc in their latest 13F filings, worth $1.36B in total (CUSIP 230031106).

Largest holders

1. MPM BioImpact LLC — $177M
2. Lynx1 Capital Management LP — $163M
3. BVF INC/IL — $105M
4. BlackRock, Inc. (BLK) — $95.3M
5. PRICE T ROWE ASSOCIATES INC /MD/ — $69.7M
6. STATE STREET CORP (STT, STT-PG) — $66.8M
7. Kynam Capital Management, LP — $56.7M
8. VANGUARD CAPITAL MANAGEMENT LLC — $47.6M
9. RTW INVESTMENTS, LP — $43.1M
10. Siren, L.L.C. — $34.5M

Famous investors holding it

• Ken Griffin portfolio (Citadel Advisors)
• Izzy Englander portfolio (Millennium Management)
• Renaissance Technologies portfolio (Renaissance Technologies)
• Two Sigma portfolio (Two Sigma Investments)

Insider buying and selling at Cullinan Therapeutics Inc

Who owns the most CGEM stock?

The largest institutional holders in the latest 13F filings are MPM BioImpact LLC ($177M), Lynx1 Capital Management LP ($163M), BVF INC/IL ($105M).

How many funds own CGEM?

193 funds reported holding it, worth $1.36B in total.